ICPMS
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike

Alternative sample preparation and analysis approach for ICH/USP controlled metals by ICP-MS

Posters |  | Agilent TechnologiesInstrumentation
ICP/MS
Industries
Pharma & Biopharma
Manufacturer
Agilent Technologies

Summary

Significance of the Topic


In pharmaceutical development, tracking both organic and inorganic impurities is crucial for ensuring drug safety, stability and compliance with regulatory standards. Elemental contaminants, originating from catalysts or production equipment, pose risks to patient health and product quality. As regulatory bodies such as ICH and USP require rigorous monitoring of elemental impurities, robust and efficient analytical methods are in demand.

Objectives and Study Overview


This study evaluates an alternative sample preparation strategy using organic solvent (DMSO) coupled with Agilent 7800 ICP-MS for quantifying ICH/USP controlled metals in active pharmaceutical ingredients (APIs). The goal was to replace time-consuming microwave acid digestion with a simpler, high-throughput approach while maintaining accuracy, precision and sensitivity.

Methodology and Instrumentation


Sample preparation involved weighing 100 mg of API into 50 mL falcon tubes, dissolving in DMSO, sonicating for 15 minutes and diluting to volume with DMSO. Calibration standards were prepared from NIST-traceable solutions in DMSO, and internal standards were introduced online via a peristaltic pump.
  • Instrument: Agilent 7800 ICP-MS
  • Sample introduction: Micromist nebulizer with Peltier-cooled quartz spray chamber
  • Optics: Platinum cones, 1.5 mm injector torch, ORS4 collision/reaction cell
  • Autosampler: Agilent SPS 4 with online internal standard addition
  • Software: ICP-MS MassHunter 4.3 with USP chapter presets

Main Results and Discussion


Accuracy studies at 100% J value showed recoveries between 70–150% with relative standard deviations well within acceptance criteria. Intermediate precision experiments, conducted on different days and instruments, yielded RSD values below 25%. System suitability tests demonstrated drift under 20% for target elements. Calibration curves for As, Cd, Hg and Pb exhibited high linearity (R values near unity) and detection limits in the low µg/L range despite the organic matrix.

Benefits and Practical Applications of the Method


The DMSO-based preparation method eliminates the need for closed-vessel microwave acid digestion, reducing sample handling time and reagent consumption. Its compatibility with Agilent 7800 ICP-MS ensures high throughput and reliable quantification of elemental impurities in APIs and excipients, supporting QC laboratories in achieving USP chapters <232>/<233> compliance.

Future Trends and Opportunities


Advancements in ICP-MS cell technologies and solvent-resistant sampling systems may further enhance sensitivity and robustness for complex organic matrices. Integration of automated sample preparation platforms and expansion to additional elements could broaden applicability across pharmaceutical workflow stages, from raw material screening to final product release.

Conclusion


The optimized organic solvent approach combined with Agilent 7800 ICP-MS offers a streamlined, compliant and high-throughput solution for elemental impurity analysis in pharmaceutical ingredients. It delivers accurate, precise and sensitive results while simplifying laboratory workflows.

References


  1. USP Chapter <232> Elemental Impurities – Limits, Pharmacopeial Forum, 2011, 42(2).
  2. USP Chapter <233> Elemental Impurities – Procedures, USP 38–NF 33, Second Supplement.

Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.

Downloadable PDF for viewing
 

Similar PDF

Toggle
Determining Elemental Impurities in Pharmaceutical Ingredients using ICP-MS
Application Note Pharmaceuticals Determining Elemental Impurities in Pharmaceutical Ingredients using ICP-MS USP/ICH methodology used to measure 24 elemental impurities in raw materials dissolved in DMSO Authors Radhey S. Dhuria, Vinay Jain, Gaurav Kapadnis and Samir Vyas Agilent Technologies, Inc. Introduction…
Key words
pharmaceutical, pharmaceuticalimpurities, impuritieselement, elementelemental, elementalusp, uspdmso, dmsostandardization, standardizationingredients, ingredientsvalue, valuegas, gasicp, icpich, ichorganic, organicmicrowave, microwaveclosed
Validating performance of an Agilent ICP‑MS for USP <232>/<233> & ICH Q3D(R2)/Q2(R1)
Application Note Pharmaceuticals Validating performance of an Agilent ICP‑MS for USP <232>/<233> & ICH Q3D(R2)/Q2(R1) Reducing the time and expense of ICP-MS method development and system validation for measuring elemental impurities in pharmaceuticals Authors Lindsey Whitecotton, Ed McCurdy, Craig Jones…
Key words
pde, pdeelemental, elementalicp, icppharmaceutical, pharmaceuticalelements, elementsspike, spikepdes, pdeselement, elementich, ichmean, meanprocedures, proceduresimpurities, impuritiesday, daypolyatomic, polyatomiclimits
USP <232>/<233> and ICH Q3D Elemental Impurities Analysis: The Agilent ICP-MS Solution
White Paper USP <232>/<233> and ICH Q3D Elemental Impurities Analysis: The Agilent ICP-MS Solution Elemental Impurity Analysis Requirements Worldwide, regulatory authorities are responsible for ensuring that pharmaceutical products are both effective and safe. Potentially toxic and harmful contaminants—including elemental impurities—must…
Key words
icp, icpelemental, elementalich, ichagilent, agilentpde, pdeusp, uspelements, elementslimits, limitsdilution, dilutionpharmaceutical, pharmaceuticalimpurities, impuritiesmasshunter, masshunterdrug, drugsoftware, softwaredaily
Proposed new ICH and USP methods for elemental impurities: The application of ICP-MS and ICP-OES for pharmaceutical analysis
Proposed new ICH and USP methods for elemental impurities: The application of ICP-MS and ICP-OES for pharmaceutical analysis White paper Authors Amir Liba, Ed McCurdy and Ross Ashdown Agilent Technologies Abstract The United States Pharmacopeial Convention (USP), in parallel with…
Key words
icp, icppharmaceutical, pharmaceuticalinorganic, inorganiclimits, limitspde, pdeparenteral, parenteralich, ichelements, elementsdigestion, digestiondrug, drugusp, uspmust, mustadministration, administrationoes, oesbenefits
Other projects
GCMS
LCMS
Follow us
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike